Quotes

Back To Menu

Alembic Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

Invest

23 Oct 2019 | 03:59 PM

49.00
-0.15 (-0.31%)

  • Outperforms Index

    52.13%

    Return (1Y)

    Beaten S&P BSE Sensex by 36.73%

  • More Volatile

    2.3%

    Standard Deviation (1Y)

    Higher than S&P BSE Sensex by 1.37%

  • Consistent Performer

    8/12

    Months

    beaten S&P BSE Sensex

  • AxisDirect View

    No View

52 Week High-Low

56

56.00

31

31.39

News & Announcements

  • Alembic AGM scheduled

    54 days ago

  • Alembic consolidated net profit rises 9.73% in the June 2019 quarter

    70 days ago

  • Board of Alembic recommends Final Dividend

    70 days ago

  • Alembic to announce Quarterly Result

    76 days ago

Price vs Volume

Stock Trivia

  • FII shareholding in Alembic Ltd has increased by 46.11% since past 3 Months

  • FII shareholding in Alembic Ltd has increased by 72.43% since past 1 Year

  • MF shareholding in Alembic Ltd has increased by 8.96% since past 1 Year

  • Promoter shareholding in Alembic Ltd has increased by 4.36% since past 1 Year

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...